<TABLE>
<CAPTION>
<S> <C> <C>
-------------------------
UNITED STATES OMB APPROVAL
SECURITIES AND EXCHANGE COMMISSION -------------------------
Washington, D.C. 20549 OMB NUMBER: 3235-0145
Expires: October 31, 1994
Estimated average burden
hours per form .... 14.90
-------------------------
SCHEDULE 13D
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
Finet Holdings Corporation
- -------------------------------------------------------------------------------------------------------
(Name of Issuer)
Common Stock
- -------------------------------------------------------------------------------------------------------
(Title of Class of Securities)
317922201
- -------------------------------------------------------------------------------------------------------
(CUSIP Number)
Jack Olshansky, 505 Sansome Street, San Francisco, California 94111 (415) 627-2560
- -------------------------------------------------------------------------------------------------------
(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communications)
November 14, 1997
- -------------------------------------------------------------------------------------------------------
(Date of Event which Requires Filing of this Statement)
If the filing person has previously filed a statement on Schedule 13G to report the acquisition which is
the subject of this Schedule 13D, and is filing this schedule because of Rule 13d-1(b)(3) or (4), check
the following box [ ].
Check the following box if a fee is being paid with the statement [ ]. (A fee is not required only if
the reporting person: (1) has a previous statement on file reporting beneficial ownership of more than
five-percent of the class of securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percept or less of such class.) (See Rule 13d-7.)
Note: Six copies of this statement, including all exhibits, should be filed with the Commission. See
Rule 13d-1(a) for other parties to whom copies are to be sent.
*The remainder of this cover page shall be filled out for a reporting person's initial filing on this
form with respect to the subject class of securities, and for any subsequent amendment containing
information which would alter disclosures provided in a prior cover page.
The information required in the reaminder of this cover page shall not be deemed to be "filed" for the
purpose of Section 18 of the Securities Exchange Act of 1934 ("Act") or otherwise subject to the
liabilities of that section of the Act but shall be subject to all other provisions of the Act (however,
see the Notes).
</TABLE>
Page 1 of 9
<PAGE>
<TABLE>
<CAPTION>
SCHEDULE 13D
<S> <C>
- ------------------- -----------------
CUSIP NO. 317922201 Page 2 of 9 Pages
- ------------------- -----------------
- -------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Montgomery Medical Ventures II, L.P.
- -------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[ ]
- -------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- -------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF SHARES -----------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 55,317
REPORTING -----------------------------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
-----------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
55,317
- -------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
55,317
- -------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
- -------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------------------------------
<FN>
*See instructions
</FN>
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SCHEDULE 13D
<S> <C>
- ------------------- -----------------
CUSIP NO. 317922201 Page 3 of 9 Pages
- ------------------- -----------------
- -------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Montgomery Medical Partners II, L.P.
- -------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[ ]
- -------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
California
- -------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF SHARES -----------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 55,317
REPORTING -----------------------------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
-----------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
55,317
- -------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
55,317
- -------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
- -------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
PN
- -------------------------------------------------------------------------------------------------------
<FN>
*See instructions
</FN>
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SCHEDULE 13D
<S> <C>
- ------------------- -----------------
CUSIP NO. 317922201 Page 4 of 9 Pages
- ------------------- -----------------
- -------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
MMV II Holding Co.
- -------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[ ]
- -------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
- -------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF SHARES -----------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 0
REPORTING -----------------------------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
-----------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
0
- -------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
0
- -------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.0%
- -------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
CO
- -------------------------------------------------------------------------------------------------------
<FN>
*See instructions
</FN>
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SCHEDULE 13D
<S> <C>
- ------------------- -----------------
CUSIP NO. 317922201 Page 5 of 9 Pages
- ------------------- -----------------
- -------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Jack Olshansky
- -------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[ ]
- -------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF SHARES -----------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 55,317
REPORTING -----------------------------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
-----------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
55,317
- -------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
55,317
- -------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
- -------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------------------------------
<FN>
*See instructions
</FN>
</TABLE>
<PAGE>
<TABLE>
<CAPTION>
SCHEDULE 13D
<S> <C>
- ------------------- -----------------
CUSIP NO. 317922201 Page 6 of 9 Pages
- ------------------- -----------------
- -------------------------------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Steven Weiss
- -------------------------------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [x]
(b) [ ]
- -------------------------------------------------------------------------------------------------------
3 SEC USE ONLY
- -------------------------------------------------------------------------------------------------------
4 SOURCE OF FUNDS*
WC
- -------------------------------------------------------------------------------------------------------
5 CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d) or 2(e)
[ ]
- -------------------------------------------------------------------------------------------------------
6 CITIZENSHIP OR PLACE OF ORGANIZATION
USA
- -------------------------------------------------------------------------------------------------------
7 SOLE VOTING POWER
0
NUMBER OF SHARES -----------------------------------------------------------------------------------
BENEFICIALLY 8 SHARED VOTING POWER
OWNED BY
EACH 55,317
REPORTING -----------------------------------------------------------------------------------
PERSON 9 SOLE DISPOSITIVE POWER
WITH
0
-----------------------------------------------------------------------------------
10 SHARED DISPOSITIVE POWER
55,317
- -------------------------------------------------------------------------------------------------------
11 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
55,317
- -------------------------------------------------------------------------------------------------------
12 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES* [ ]
- -------------------------------------------------------------------------------------------------------
13 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
0.2%
- -------------------------------------------------------------------------------------------------------
14 TYPE OF REPORTING PERSON*
IN
- -------------------------------------------------------------------------------------------------------
<FN>
*See instructions
</FN>
</TABLE>
<PAGE>
This Amendment No. 4 to Schedule 13D ("Amendment No. 4") amends the
Statement on Schedule 13D filed jointly by Montgomery Medical Ventures II, L.P.,
a California limited partnership ("MMV"), Advanced Medical, Inc., a Delaware
Corporation ("AMI"), and AMT Cosmeceuticals, Inc., a Delaware corporation
("AMT"), as amended by Amendment No. 1 jointly filed on October 12, 1992 by MMV,
AMI, AMT, Montgomery Medical Partners II, L.P., a California limited partnership
("MMP"), Richard D. Propper, an individual ("Propper"), Jack Olshansky, an
individual ("Olshansky"), Steven Weiss, an individual ("Weiss"), and Stephen
Sogin, an individual ("Sogin"), Amendment No. 2 jointly filed in May, 1994 by
MMV, MMP, MMVII Holding Co. ("Holding"), Olshansky, Weiss, and Sogin, and
Amendment No. 3 jointly filed on February 14, 1995 by MMV, MMP, Holding,
Olshansky, Weiss and Sogin, relating to the Common Stock, par value $0.01 per
share (the "Common Stock") of Finet Holdings Corporation, a Delaware corporation
(the "Company").
Item 4: Purpose of Transaction.
Item 4 shall be amended by adding the following paragraph at the end of
the section:
On July 15, 1997, Holding sold 3,483 shares of Common Stock, its
remaining ownership position.
MMV sold shares of Common Stock on the following dates:
DATE SHARES
---- ------
7/15/97 7,917
11/5/97 5,000
11/7/97 100,000
11/10/97 62,000
11/11/97 19,000
11/14/97 500,000
Item 5: Interest in Securities of the Issuer.
The response to Item 5 is hereby amended and restated in its entirety
to read as follows:
(a) through (e) The aggregate number of shares of Common Stock
beneficially owned by the Reporting Persons as of November 14, 1997 are
based upon 28,973,618 shares of Common Stock outstanding as of August
5, 1997. The increase in the Company's Common Stock outstanding
reflects shares issued as a result of acquisitions, private placements,
debt and note payable conversions, liability settlements, common stock
rights, and exercise of stock options, net of common stock repurchases.
As a result of the increased number of Company shares outstanding,
before the transactions reported in this amendment, the Reporting
Persons owned less than a 5% interest . The Company's Common Stock
outstanding also reflects a 1 for 2 reverse stock split effected
October 21, 1996.
As a result of the July 1997 and November 1997 sales, as set forth in
item 4 above, MMV, MMP, Olshansky, and Weiss own 55,317 shares of
Common Stock. Holding owns no shares of Common Stock. This is the
Reporting Persons final 13D amendment for Finet Holdings Corporation
and a voluntary exit filing.
<PAGE>
Item 7. Material to Be Filed as Exhibits.
The response to Item 7 is hereby amended to include the following
exhibit items:
Exhibit 7.1 Amended Joint Filing Agreement
Exhibit 1
JOINT FILING AGREEMENT
Pursuant to Rule 13d-1 (f)(1), we the undersigned agree that this
Amendment to Statement on Schedule 13D, to which this Joint Filing Agreement is
attached as Exhibit 1, is filed on behalf of each of us.
Dated: November 17, 1997
Montgomery Medical Ventures II, L.P.
By: Montgomery Medical Partners II, L.P.
By: /s/ Jack Olshansky
----------------------------
Jack Olshansky
General Partner
Montgomery Medical Partners II, L.P.
By: /s/ Jack Olshansky
----------------------------
Jack Olshansky
General Partner
/s/ Jack Olshansky
----------------------------
Jack Olshansky
/s/ Steven Weiss
----------------------------
Steven Weiss
MMV Holding II Co.
By: Montgomery Medical Ventures II, L.P.
By: Montgomery Medical Partners II, L.P.
By: /s/ Jack Olshansky
------------------------------------
Jack Olshansky
General Partner
